Liposomal amphotericin B-the past

Keyphrases

• Liposomal Amphotericin B 100%
• Liposomal Formulation 66%
• Clinical Efficacy 33%
• International Guidelines 33%
• Infectious Diseases 33%
• Aspergillus 33%
• Fungal Infection 33%
• Amphotericin B 33%
• Safety Profile 33%
• Efficacy Profile 33%
• Drug Concentration 33%
• Visceral Leishmaniasis 33%
• Pharmacokinetic Profile 33%
• Systemic Fungal Infections 33%
• Microbiological Data 33%
• Preclinical Efficacy 33%
• Therapeutic Index 33%
• Amphotericin B Deoxycholate 33%
• Common Infections 33%
• Candida Infection 33%
• Polyene Antifungals 33%
• Liposomal Drug Delivery System 33%
• Antifungal Compounds 33%
• Cryptococcal Infection 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Amphotericin B 100%
• Disease 25%
• Clinical Study 25%
• Infection 25%
• Drug Delivery System 25%
• Therapeutic Window 25%
• Infectious Agent 25%
• Aspergillus 25%
• Systemic Mycosis 25%
• Drug Concentration 25%
• Visceral Leishmaniasis 25%
• Liposomal Drug Delivery 25%
• Antifungal Therapy 25%
• Candidiasis 25%
• Amphotericin B Deoxycholate 25%
• Polyene 25%
• Pharmacokinetics 25%